Novo Integrated Sciences and CannaPiece Group Sign Share Exchange Agreement and Close $1,867,250 Subscription AgreementNovo Integrated Sciences, Inc. • December 21st, 2018 • Engines & turbines
BELLEVUE, Wash., December 21, 2018 (GLOBE NEWSWIRE) — via OTC PR WIRE — Novo Integrated Sciences, Inc. (OTCQB:NVOS) (the “Company” or “Novo Integrated Sciences”) and Novo Healthnet Limited (“NHL”), a wholly owned Canadian subsidiary of the Company, are pleased to announce the signing of a definitive Share Exchange Agreement (“SEA”), dated December 18, 2018, with CannaPiece Group Inc. (“CannaPiece”), an Ontario province corporation and a late stage applicant for issuance, from Health Canada, of a cannabis cultivation, extraction and sale license under the Access to Cannabis for Medical Purposes Regulations.
SHARE EXCHANGE AGREEMENT by and among Novo Integrated Sciences, Inc.; Novo Healthnet Limited; And CannaPiece Group Inc.Share Exchange Agreement • December 21st, 2018 • Novo Integrated Sciences, Inc. • Engines & turbines • Nevada
This Share Exchange Agreement (this “Agreement”) is entered into as of the date first set forth above (the “Effective Date”) by and between (i) Novo Integrated Sciences, Inc., a Nevada corporation (the “Parent”); (ii) Novo Healthnet Limited, a limited company incorporated under the Laws (as defined below) of the Province of Ontario, Canada (“NHL” and together with the Parent, the “Buyer”) and (iii) CannaPiece Group Inc., an Ontario, Canada corporation (“CPG”, “Seller”). Each of the Parent, NHL and CPG may be referred to herein collectively as the “Parties” and separately as a “Party.”
